Access the world's leading financial data and tools

Subscribe for $2
Overview
Profile

Zimmer Biomet Holdings stock

ZBH
US98956P1021
753718

Price

110.33
Today +/-
+1.29
Today %
+1.28 %
P

Zimmer Biomet Holdings stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Zimmer Biomet Holdings stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Zimmer Biomet Holdings stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Zimmer Biomet Holdings stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Zimmer Biomet Holdings's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Zimmer Biomet Holdings Stock Price History

DateZimmer Biomet Holdings Price
11/6/2024110.33 undefined
11/5/2024108.92 undefined
11/4/2024108.41 undefined
11/1/2024107.27 undefined
10/31/2024106.92 undefined
10/30/2024109.81 undefined
10/29/2024103.88 undefined
10/28/2024103.60 undefined
10/25/2024102.35 undefined
10/24/2024104.00 undefined
10/23/2024104.70 undefined
10/22/2024104.26 undefined
10/21/2024105.20 undefined
10/18/2024106.31 undefined
10/17/2024104.95 undefined
10/16/2024105.46 undefined
10/15/2024104.60 undefined
10/14/2024104.83 undefined
10/11/2024103.50 undefined
10/10/2024102.82 undefined
10/9/2024103.46 undefined
10/8/2024101.77 undefined

Zimmer Biomet Holdings Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Zimmer Biomet Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Zimmer Biomet Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Zimmer Biomet Holdings’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Zimmer Biomet Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Zimmer Biomet Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Zimmer Biomet Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Zimmer Biomet Holdings’s growth potential.

Zimmer Biomet Holdings Revenue, EBIT and net profit per share

DateZimmer Biomet Holdings RevenueZimmer Biomet Holdings EBITZimmer Biomet Holdings Net Income
2029e10 B undefined0 undefined2.33 B undefined
2028e9.27 B undefined2.85 B undefined1.89 B undefined
2027e8.95 B undefined2.72 B undefined1.99 B undefined
2026e8.5 B undefined2.48 B undefined1.86 B undefined
2025e8.12 B undefined2.34 B undefined1.72 B undefined
2024e7.74 B undefined2.2 B undefined1.6 B undefined
20237.39 B undefined1.47 B undefined1.02 B undefined
20226.94 B undefined1.23 B undefined231.4 M undefined
20216.83 B undefined1.06 B undefined401.6 M undefined
20207.02 B undefined748.8 M undefined-138.9 M undefined
20197.98 B undefined1.31 B undefined1.13 B undefined
20187.93 B undefined1.32 B undefined-379.2 M undefined
20177.8 B undefined1.59 B undefined1.81 B undefined
20167.67 B undefined1.32 B undefined305.9 M undefined
20156 B undefined1.3 B undefined147 M undefined
20144.67 B undefined1.38 B undefined720.3 M undefined
20134.62 B undefined1.27 B undefined780.4 M undefined
20124.47 B undefined1.3 B undefined755 M undefined
20114.45 B undefined1.1 B undefined760.8 M undefined
20104.22 B undefined1.16 B undefined596.9 M undefined
20094.1 B undefined1.17 B undefined717.4 M undefined
20084.12 B undefined1.16 B undefined848.6 M undefined
20073.9 B undefined1.32 B undefined773.2 M undefined
20063.5 B undefined1.17 B undefined834.5 M undefined
20053.29 B undefined1.11 B undefined732.5 M undefined
20042.98 B undefined844.3 M undefined541.8 M undefined

Zimmer Biomet Holdings Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (B)EBIT (B)EBIT MARGIN (%)NET INCOME (B)NET INCOME GROWTH (%)DIV. ()DIV. GROWTH (%)SHARES (M)DOCUMENTS
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024e2025e2026e2027e2028e2029e
0.860.941.041.181.371.92.983.293.53.94.124.14.224.454.474.624.6767.677.87.937.987.026.836.947.397.748.128.58.959.2710
-9.0610.8613.1616.4738.5656.7610.276.3611.505.75-0.633.055.470.453.401.0828.3327.861.761.650.63-12.00-2.801.646.564.674.914.685.273.577.93
69.2271.3572.0572.7574.8572.8073.8677.4877.6877.5275.7875.8076.0274.7574.8872.4273.4069.9867.7972.6071.7071.3069.7071.2870.9071.81------
0.60.670.750.861.031.382.22.552.723.023.123.13.213.333.353.353.434.25.25.675.695.694.94.874.925.31000000
0.210.230.270.250.40.540.841.111.171.321.161.171.161.11.31.271.381.31.321.591.321.310.751.061.231.472.22.342.482.722.850
24.5124.6025.7421.0529.1528.4628.3233.8133.5133.9228.1028.5027.3724.6229.0827.4929.4921.6617.2420.3316.6416.4510.6515.5017.6519.9128.4728.8729.2230.3630.70-
0.150.150.180.150.260.350.540.730.830.770.850.720.60.760.760.780.720.150.311.81-0.381.13-0.140.40.231.021.61.721.861.991.892.33
-3.4517.33-15.3472.4834.6356.3635.3013.93-7.319.70-15.45-16.8827.52-0.663.31-7.69-79.58107.48494.43-120.90-398.42-112.20-390.58-42.39343.2956.157.577.857.22-4.7823.23
--------------------------------
--------------------------------
193.8193.6193.6194.3196.8211.2247.8249.8245.4237.5228.3215.8201.1188.7176171.8171.7189.8202.4203.7203.5206.7207210.4210.3209.7000000
--------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Zimmer Biomet Holdings Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Zimmer Biomet Holdings is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (B)RECEIVABLES (B)OTHER REC. (M)INVENTORIES (B)OTHER CURRENT LIAB. (M)CURRENT ASSETS (B)TANGIBLE ASSETS (B)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (B)GOODWILL (B)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (B)TOTAL ASSETS (B)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (B)RETAINED EARNINGS (B)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (k)EQUITY (B)LIABILITIES (M)PROVISIONS (B)OTHER SHORT-TERM LIAB. (B)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (B)SHORT-TERM REC. (B)LONG-T. LIAB. (B)DEFERRED TAXES (B)OTHER LIAB. (B)LONG-T. LIABILITIES (B)DEBT (B)TOTAL CAPITAL (B)
1999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
                                                 
000.020.020.080.160.230.270.460.210.760.931.221.561.811.71.620.630.520.540.620.80.480.380.42
0.20.190.180.220.490.530.520.630.670.730.750.780.840.890.940.911.451.61.541.281.361.451.41.381.44
0000000000000000000000000
0.150.150.20.260.530.540.580.640.730.930.910.940.9311.081.192.251.962.072.262.392.452.392.152.39
8478108125248346235217216305315364285273379513530466429352357378607.1522.9732.2
0.430.420.510.611.341.561.581.752.082.182.743.013.283.714.24.315.864.664.574.434.725.084.894.434.98
0.110.120.150.160.530.630.710.810.971.261.221.211.211.211.231.292.062.042.042.022.342.322.292.072.26
000035000000000000000006.700
0000000000000000000000000
00000.760.80.760.710.740.870.860.830.80.740.710.68.758.798.357.697.267.066.35.064.86
00002.292.532.432.522.622.782.782.582.632.572.612.519.9310.6410.679.599.69.269.198.588.82
62608889205182252193214149184369607781839942564554389405713695791.7925.8948.3
0.180.180.240.253.824.144.154.234.555.065.054.995.245.315.385.3521.3122.0221.4519.719.9219.3418.5816.6416.89
0.610.60.740.865.165.75.725.986.637.247.7988.529.019.589.6627.1626.6826.0124.1324.6424.4223.4621.0721.86
                                                 
00222333333333333333333.13.13.2
0000.042.342.492.62.7433.143.223.293.43.544.338.28.378.528.698.929.129.319.59.85
000.060.310.661.21.932.773.544.395.15.76.437.097.718.368.358.4710.029.4910.4310.0910.299.5610.38
391261171413925314920929024035932127134436739-329-434-83-187-242-298-231.6-179.3-191.1
000000000000001,0000000000000
0.390.260.080.373.143.944.695.726.837.778.689.3210.110.9312.0912.7416.2216.4118.4617.9919.1118.9119.3818.8920.04
98506760128132124158174186135130143184146145285365330363401330351.2354.1410.6
0.110.130.150.170.480.5100.250.340.330.390.420.470.470.530.6401.091.030.931.161.291.160.971.1
0.010.0100.02-0.060.030.480.220.240.260.170.160.120.120.360.241.330.350.480.60.380.440.350.490.45
001501571012800000014310010000000000
000000000000000000.581.230.531.50.51.610.540.9
0.220.190.370.40.650.70.610.630.750.770.690.70.870.871.031.021.622.383.072.423.442.563.472.362.86
000.2101.010.620.080.10.10.461.131.141.581.721.671.4311.510.678.928.46.727.635.465.154.87
0000000000000000.053.153.031.110.840.790.670.470.36
00.150.080.090.350.420.350.320.330.350.330.380.560.560.580.611.010.941.191.031.251.251.191.050.93
00.150.290.091.361.050.430.420.430.811.461.532.132.282.252.0815.6514.6311.2110.438.89.667.326.686.15
0.220.340.670.492.011.751.041.051.181.592.152.2333.153.283.1117.2717.0214.2812.8512.2512.2210.799.049.01
0.610.60.740.865.155.695.726.788.019.3510.8311.5513.114.0815.3715.8433.4933.4232.7430.8531.3531.1330.1727.9329.05
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Zimmer Biomet Holdings provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Zimmer Biomet Holdings's financial health and stability.

Assets

Zimmer Biomet Holdings's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Zimmer Biomet Holdings must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Zimmer Biomet Holdings after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Zimmer Biomet Holdings's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (B)DEPRECIATION (B)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (B)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (B)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (B)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (B)CASH FLOW FROM OTHER FINANCING ACTIVITIES (M)TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0.150.150.180.150.260.350.540.730.830.770.850.720.60.760.750.780.720.150.31.81-0.381.13-0.140.450.291.03
0.030.020.020.020.030.10.180.190.20.230.280.340.340.360.360.360.380.711.041.061.041.011.030.940.930.95
000000000632-19-72-19-64-126-90-164-153-1,77613-53812-102-64-96
28833-1-625737-79-70-67-170-4958-3-63-134-32-383-226427-167-427-134-311-396
00000-0.010.10.040.080.080.150.210.330.140.220.130.130.550.520.471.110.240.80.430.550.2
000413627155814170000000317282226193219161200
00043114116143189257255332268330236227272340193269266237192147258326215
0.20.180.230.170.220.490.860.881.041.081.041.121.191.181.150.961.050.821.631.581.751.591.21.51.281.58
-20-33-29-54-33-158-240-255-268-331-597-264-280-288-264-292-342-434-530-493-439-720-409-417-446-689
-20-33-29-54-35-1,102-388-311-287-491-924-381-726-624-592-282-469-7,557-1,691-510-416-729-613-503-529-778
0000-2-944-147-55-18-160-326-116-446-336-32710-127-7,123-1,161-1722-8-204-86-83-89
00000000000000000000000000
0000.37-0.210.62-0.46-0.560.0200.330.67-00.550.1-0.1-0.257.39-0.26-1.25-1.15-0.72-0.25-1.06-1.060.05
000123706572-749-399-673-913-487-1,001-436-237-105-33-278145107158129122-48-591
-0.18-0.15-0.2-0.1-0.190.66-0.4-0.48-0.73-0.4-0.34-0.26-0.49-0.46-0.44-0.47-0.567.14-0.74-1.21-1.3-0.78-0.42-1.31-0.84-0.76
-179-147-203-1760-26-5-1000-170-4-30-64-58-1685-60-25-100-173466-26
000-2900000000000-94-132-145-157-188-193-195-196-198-200-201-200
00018-261777832198-251479-22991161962376-825-1091875184-323-10240
179147203117.1186.5336.3621.8622.9772.4753.2440.8852.9913.3888.8887.4670.2710.5382.61,1021,089.31,308.4865.2794.91,082838.5892.4
00000000000000000000000000

Zimmer Biomet Holdings stock margins

The Zimmer Biomet Holdings margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Zimmer Biomet Holdings. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Zimmer Biomet Holdings.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Zimmer Biomet Holdings's sales revenue. A higher gross margin percentage indicates that the Zimmer Biomet Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Zimmer Biomet Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Zimmer Biomet Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Zimmer Biomet Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Zimmer Biomet Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Zimmer Biomet Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Zimmer Biomet Holdings Margin History

Zimmer Biomet Holdings Gross marginZimmer Biomet Holdings Profit marginZimmer Biomet Holdings EBIT marginZimmer Biomet Holdings Profit margin
2029e71.82 %0 %23.34 %
2028e71.82 %30.7 %20.45 %
2027e71.82 %30.36 %22.24 %
2026e71.82 %29.22 %21.83 %
2025e71.82 %28.87 %21.2 %
2024e71.82 %28.47 %20.67 %
202371.82 %19.92 %13.85 %
202270.9 %17.66 %3.33 %
202171.29 %15.5 %5.88 %
202069.7 %10.66 %-1.98 %
201971.3 %16.46 %14.18 %
201871.69 %16.64 %-4.78 %
201772.6 %20.33 %23.24 %
201667.8 %17.25 %3.99 %
201569.98 %21.66 %2.45 %
201473.41 %29.5 %15.41 %
201372.43 %27.49 %16.88 %
201274.88 %29.09 %16.88 %
201174.74 %24.63 %17.09 %
201076.02 %27.38 %14.14 %
200975.81 %28.5 %17.52 %
200875.8 %28.11 %20.59 %
200777.53 %33.93 %19.84 %
200677.68 %33.51 %23.87 %
200577.5 %33.83 %22.29 %
200473.84 %28.32 %18.18 %

Zimmer Biomet Holdings Stock Sales Revenue, EBIT, Earnings per Share

The Zimmer Biomet Holdings earnings per share therefore indicates how much revenue Zimmer Biomet Holdings has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zimmer Biomet Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zimmer Biomet Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zimmer Biomet Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zimmer Biomet Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zimmer Biomet Holdings Revenue, EBIT and net profit per share

DateZimmer Biomet Holdings Sales per ShareZimmer Biomet Holdings EBIT per shareZimmer Biomet Holdings Earnings per Share
2029e50.24 undefined0 undefined11.73 undefined
2028e46.55 undefined0 undefined9.52 undefined
2027e44.94 undefined0 undefined10 undefined
2026e42.69 undefined0 undefined9.32 undefined
2025e40.78 undefined0 undefined8.64 undefined
2024e38.88 undefined0 undefined8.04 undefined
202335.26 undefined7.02 undefined4.88 undefined
202233 undefined5.83 undefined1.1 undefined
202132.45 undefined5.03 undefined1.91 undefined
202033.93 undefined3.62 undefined-0.67 undefined
201938.62 undefined6.36 undefined5.47 undefined
201838.98 undefined6.49 undefined-1.86 undefined
201738.31 undefined7.79 undefined8.9 undefined
201637.89 undefined6.54 undefined1.51 undefined
201531.6 undefined6.84 undefined0.77 undefined
201427.22 undefined8.03 undefined4.2 undefined
201326.91 undefined7.4 undefined4.54 undefined
201225.41 undefined7.39 undefined4.29 undefined
201123.59 undefined5.81 undefined4.03 undefined
201020.99 undefined5.75 undefined2.97 undefined
200918.98 undefined5.41 undefined3.32 undefined
200818.05 undefined5.07 undefined3.72 undefined
200716.41 undefined5.57 undefined3.26 undefined
200614.24 undefined4.77 undefined3.4 undefined
200513.15 undefined4.45 undefined2.93 undefined
200412.03 undefined3.41 undefined2.19 undefined

Zimmer Biomet Holdings business model

Zimmer Biomet Holdings Inc is a global company in the medical technology industry that provides innovative products and solutions for orthopedic, dental, and surgical applications. The company was formed through the merger of Zimmer Holdings Inc and Biomet Inc in 2015 and is headquartered in Indiana, USA. The history of Zimmer Biomet Holdings dates back to 1927 when Justin Zimmer founded Zimmer Manufacturing Company, which specialized in the production of orthopedic instruments and prostheses. In 1939, the company introduced the first modular hip endoprosthesis and over the years established itself as a leading provider of orthopedic implants and instruments. Biomet Inc was founded in 1977 with the goal of developing groundbreaking solutions for orthopedic implants. Both companies grew rapidly through acquisitions, strategic partnerships, and innovations before eventually merging. The business model of Zimmer Biomet Holdings focuses on supporting patients and medical professionals in improving quality of life and health. The company offers a wide range of products and services tailored to the needs of patients and medical professionals. These range from joint implants, spine, and knee instruments to digital solutions and patient care services. The company operates in various divisions specializing in different areas of medical technology. The Joint Reconstruction division offers a comprehensive range of implants for hips, knees, shoulders, and elbows, as well as instruments required for orthopedic and surgical procedures. The Surgical division provides products and solutions for surgical procedures, including spine, sports, and trauma surgery. Dental supplies products for dentistry, including implants, instruments, and digital solutions. Additionally, there is the Craniomaxillofacial and Thoracic Surgery division, which focuses on providing care for patients with bone and soft tissue tumors, as well as facial trauma reconstruction. Zimmer Biomet Holdings products are distributed in over 100 countries worldwide and are recognized by medical professionals and patients alike. Some of the most well-known products include the NexGen hip and knee prostheses, Trabecular Metal implants, and digital solutions for patient care such as the Zimmer Biomet mymobility service. In addition to its products and services, Zimmer Biomet Holdings pursues a variety of initiatives and partnerships to improve healthcare and patient outcomes. This includes research projects in collaboration with universities, research institutions, and medical societies, as well as the exchange of best practices among medical professionals. Overall, Zimmer Biomet Holdings has established itself as a leading provider of innovative products and solutions for orthopedic, dental, and surgical applications. With its comprehensive range of products and services and global presence, the company sets standards for healthcare and patient care. Zimmer Biomet Holdings is one of the most popular companies on Eulerpool.com.

Zimmer Biomet Holdings SWOT Analysis

Strengths

Zimmer Biomet Holdings Inc, a global leader in the orthopedic medical device industry, possesses several key strengths:

  • Strong Brand Reputation: Zimmer Biomet has established a trusted and recognized brand name in the medical device market.
  • Wide Product Portfolio: The company offers a comprehensive range of orthopedic products, including implants, surgical tools, and biologics.
  • Extensive Global Presence: Zimmer Biomet operates in over 100 countries, giving them a significant global footprint and market access.
  • Robust Research and Development: The company invests heavily in R&D, allowing them to stay at the forefront of technological advancements in the industry.
  • Strong Distribution Network: Zimmer Biomet has a well-established distribution network, ensuring efficient product delivery to healthcare providers.

Weaknesses

Despite its strengths, Zimmer Biomet also faces certain weaknesses:

  • Product Recalls: The company has experienced occasional product recalls, which can harm its reputation and customer trust.
  • High Dependence on Healthcare Regulations: Zimmer Biomet's operations are significantly affected by regulatory changes, which can pose challenges in compliance and market approval processes.
  • Intense Competition: The orthopedic medical device industry is highly competitive, increasing pressure on pricing, innovation, and market share.

Opportunities

Zimmer Biomet can explore several opportunities to further grow its business:

  • Global Aging Population: The increasing aging population worldwide presents a growing market for orthopedic medical devices, particularly joint replacements.
  • Technological Advancements: Innovations such as 3D printing, robotics, and biologics offer Zimmer Biomet opportunities to enhance product offerings and improve patient outcomes.
  • Expansion into Emerging Markets: Zimmer Biomet can target untapped markets in developing countries, where there is a rising demand for quality orthopedic healthcare.

Threats

Zimmer Biomet should be cautious of the following potential threats:

  • Economic Volatility: Fluctuations in global economic conditions can impact healthcare spending and reduce demand for costly medical devices.
  • Stringent Regulatory Environment: Increasing regulations and stricter approval processes can delay product launches and hinder market expansion for Zimmer Biomet.
  • Product Liability and Litigation: The company may face legal challenges related to product safety and liability, leading to financial loss and damage to reputation.

Zimmer Biomet Holdings Revenue by Segment

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Zimmer Biomet Holdings Revenue by Segment

Segmente2015
Hips-
Knees-
Other-
S.E.T-
Dental & Spine-
Other product category-
SET-
Dental, Spine & CMFT-
Dental-
Spine and CMF-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Zimmer Biomet Holdings Revenue by Segment

Segmente2015
Knees2.28 B USD
Hips1.54 B USD
SET1.21 B USD
Spine And CMF404.4 M USD
Dental335.7 M USD
Other Product Category228.8 M USD
Spine and CMF-
Other product category-
Extremities-
Reconstructive implants-
Trauma-
Spine-
Surgical and other-

  • 3 years

  • 5 years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Segment

The chart visualizes revenues by segments and provides a clear overview of the revenue distribution. Each segment is clearly marked to facilitate comparisons of revenues.

Interpretation and Use

The chart enables quick identification of the highest-revenue segments, which is helpful in strategic decision-making. It supports the analysis of growth potentials and targeted resource allocation.

Investment Strategy

An investment strategy determines how capital is deliberately invested into various asset classes to maximize returns. It is based on risk tolerance, investment objectives, and a long-term plan.

Zimmer Biomet Holdings Revenue by Segment

Segmente2015
Biomet1.6 B USD

Zimmer Biomet Holdings Revenue by Region

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Details

Revenue by Segment

ⓘ

Overview of Revenue by Region

The chart shows revenues by region and provides a clear comparison of regional revenue distribution. Each region is clearly marked to illustrate the differences.

Interpretation and Usage

The diagram helps to identify the regions with the highest revenue and to make targeted decisions for regional expansion or investments. It supports the analysis of market potentials and strategic priorities.

Investment Strategy

An investment strategy focused on regions concentrates on the deliberate capital allocation in different markets to optimally use regional growth opportunities. It takes into account market conditions and regional risk factors.

Zimmer Biomet Holdings Revenue by Segment

DateAmericasAmericas and Global BusinessesAmericas OrthopedicsAmericas Spine and Global DentalAsia PacificEMEAEuropeImmaterial product category operating segmentsImmaterial Product Category Operating Segments[Member]InternationalSegment Geographical Groups Of Countries Group OneSegment geographical groups of countries group threeSegment Geographical Groups Of Countries Group ThreeSegment Geographical Groups Of Countries Group TwoSegment Geographical Groups Of Countries Group Two MemberU.S. and Puerto RicoUnited States
20224.3 B USD--------2.93 B USD-----4.01 B USD-
20214.8 B USD-4.1 B USD882 M USD1.36 B USD1.67 B USD----------4.53 B USD
20204.34 B USD4.48 B USD--1.3 B USD1.39 B USD---------4.12 B USD-
20194.88 B USD---1.36 B USD1.75 B USD---------4.59 B USD-
20183.93 B USD---1.24 B USD1.58 B USD-1.19 B USD-------4.56 B USD-
20173.95 B USD---1.16 B USD1.52 B USD-1.19 B USD---------
20163.95 B USD---1.09 B USD1.57 B USD-1.08 B USD---------
20153.11 B USD---881.6 M USD1.3 B USD--703.9 M USD--------
20142.59 B USD---809.6 M USD-1.27 B USD----------
20132.62 B USD---791 M USD-1.21 B USD----------
2012----------2.48 B USD818 M USD-1.18 B USD---
20112.44 B USD-----------796.5 M USD-1.21 B USD--

Zimmer Biomet Holdings Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Zimmer Biomet Holdings historical P/E ratio, EBIT multiple, and P/S ratio

Zimmer Biomet Holdings shares outstanding

The number of shares was Zimmer Biomet Holdings in 2023 — This indicates how many shares 209.7 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Zimmer Biomet Holdings earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Zimmer Biomet Holdings's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Zimmer Biomet Holdings’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Zimmer Biomet Holdings's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Zimmer Biomet Holdings dividend history and estimates

In 2023, Zimmer Biomet Holdings paid a dividend amounting to 0.96 USD. Dividend means that Zimmer Biomet Holdings distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Zimmer Biomet Holdings provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Zimmer Biomet Holdings’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Zimmer Biomet Holdings's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Zimmer Biomet Holdings Dividend History

DateZimmer Biomet Holdings Dividend
2029e0.97 undefined
2028e0.97 undefined
2027e0.97 undefined
2026e0.97 undefined
2025e0.97 undefined
2024e0.97 undefined
20230.96 undefined
20220.96 undefined
20210.96 undefined
20200.96 undefined
20190.96 undefined
20180.96 undefined
20170.96 undefined
20160.96 undefined
20150.88 undefined
20140.88 undefined
20130.8 undefined
20120.72 undefined

Zimmer Biomet Holdings dividend payout ratio

In 2023, Zimmer Biomet Holdings had a payout ratio of 51.78%. The payout ratio indicates the percentage of the company's profits that Zimmer Biomet Holdings distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Zimmer Biomet Holdings represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Zimmer Biomet Holdings could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Zimmer Biomet Holdings's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Zimmer Biomet Holdings Payout Ratio History

DateZimmer Biomet Holdings Payout ratio
2029e62.87 %
2028e64.01 %
2027e63.8 %
2026e60.8 %
2025e67.42 %
2024e63.19 %
202351.78 %
202287.27 %
202150.53 %
2020-143.28 %
201917.55 %
2018-51.61 %
201710.79 %
201663.58 %
2015114.29 %
201420.95 %
201317.62 %
201216.78 %
201151.78 %
201051.78 %
200951.78 %
200851.78 %
200751.78 %
200651.78 %
200551.78 %
200451.78 %

The World’s Best Investors Are On Eulerpool

Unfortunately, there are currently no price targets and forecasts available for Zimmer Biomet Holdings.

Zimmer Biomet Holdings latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/20241.76 1.74  (-0.88 %)2024 Q3
6/30/20242.01 2.01  (0.07 %)2024 Q2
3/31/20241.89 1.94  (2.75 %)2024 Q1
12/31/20232.18 2.2  (1.1 %)2023 Q4
9/30/20231.61 1.65  (2.26 %)2023 Q3
6/30/20231.83 1.82  (-0.43 %)2023 Q2
3/31/20231.66 1.89  (14.19 %)2023 Q1
12/31/20221.84 1.88  (1.9 %)2022 Q4
9/30/20221.57 1.58  (0.6 %)2022 Q3
6/30/20221.66 1.82  (9.51 %)2022 Q2
1
2
3
4
5
...
10

Eulerpool ESG Scorecard© for the Zimmer Biomet Holdings stock

Eulerpool World ESG Rating (EESG©)

70/ 100

🌱 Environment

57

👫 Social

99

🏛️ Governance

53

Environment

Scope 1 - Direct Emissions
11,294
Scope 2 - Indirect emissions from purchased energy
105,803
Scope 3 - Indirect emissions within the value chain
Total CO₂ emissions
117,097
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather
Pesticides
Palm Oil
Tobacco
Genetically modified organisms
Climate concept
Sustainable forestry
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency

Social

Percentage of female employees35.5
Percentage of women in management
Percentage of Asian employees
Share of Asian management
Percentage of Hispanic/Latino employees
Hispano/Latino Management share
Percentage of Black employees
Black Management Share
Percentage of white employees
White Management Share
Adult content
Alcohol
Weapons
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept
Occupational health and safety
Catholic

Governance (Corporate Governance)

Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Zimmer Biomet Holdings shareholders

%
Name
Stocks
Change
Date
11.71072 % The Vanguard Group, Inc.23,312,528-371,9816/30/2024
8.41193 % Dodge & Cox16,745,630326,3606/30/2024
6.08428 % T. Rowe Price Associates, Inc.12,111,9821,843,0436/30/2024
5.75244 % BlackRock Institutional Trust Company, N.A.11,451,390-196,3476/30/2024
4.62951 % State Street Global Advisors (US)9,215,969-89,7916/30/2024
3.24702 % American Century Investment Management, Inc.6,463,845722,0416/30/2024
2.53910 % PRIMECAP Management Company5,054,590-8,3606/30/2024
2.38787 % Geode Capital Management, L.L.C.4,753,5333,7486/30/2024
2.17772 % Invesco Advisers, Inc.4,335,182-815,5076/30/2024
1.87711 % Van Eck Associates Corporation3,736,761411,1639/30/2024
1
2
3
4
5
...
10

Zimmer Biomet Holdings Executives and Management Board

Mr. Ivan Tornos(48)
Zimmer Biomet Holdings President, Chief Executive Officer, Director (since 2018)
Compensation 6.44 M
Mr. Suketu Upadhyay(53)
Zimmer Biomet Holdings Chief Financial Officer, Executive Vice President - Finance, Operations and Supply Chain
Compensation 5.52 M
Mr. Wilfred Van Zuilen(53)
Zimmer Biomet Holdings President - Europe, Middle East and Africa
Compensation 4.08 M
Mr. Sang Yi(59)
Zimmer Biomet Holdings President, Asia Pacific
Compensation 3.57 M
Mr. Chad Phipps(51)
Zimmer Biomet Holdings Senior Vice President, General Counsel, Secretary
Compensation 3.23 M
1
2
3
4

Zimmer Biomet Holdings Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
BioCardia Stock
BioCardia
SupplierCustomer0,860,790,330,180,910,82
CUREXO Stock
CUREXO
SupplierCustomer0,830,750,720,100,580,60
Conformis Stock
Conformis
SupplierCustomer0,750,850,440,460,820,50
Lisi Stock
Lisi
SupplierCustomer0,700,600,130,130,490,22
PTC Inc. Stock
PTC Inc.
SupplierCustomer0,700,87-0,300,100,850,61
WNS (Holdings) Limited Stock
WNS (Holdings) Limited
SupplierCustomer0,680,830,690,59-0,10-0,19
Kunshan Kersen Science & Technology Co.,Ltd. Stock
Kunshan Kersen Science & Technology Co.,Ltd.
SupplierCustomer0,660,030,210,24-0,07-0,13
Luminex Corporation Stock
Luminex Corporation
SupplierCustomer0,65-0,03-0,05-0,21-0,58
ZimVie Stock
ZimVie
SupplierCustomer0,620,54
Desktop Metal A Stock
Desktop Metal A
SupplierCustomer0,590,760,650,570,910,68
1
2

Most common questions regarding Zimmer Biomet Holdings

What values and corporate philosophy does Zimmer Biomet Holdings represent?

Zimmer Biomet Holdings Inc represents a strong commitment to improving the quality of life for patients worldwide. With a focus on innovative medical solutions, Zimmer Biomet strives to provide effective and reliable orthopedic products and services. The company emphasizes integrity, collaboration, and excellence in everything it does, and aims to be a trusted partner for healthcare professionals. Zimmer Biomet's corporate philosophy revolves around delivering personalized treatment options, enhancing patient outcomes, and promoting sustainable healthcare solutions. By consistently pushing boundaries and investing in research and development, Zimmer Biomet aims to revolutionize orthopedic care and improve the lives of people around the globe.

In which countries and regions is Zimmer Biomet Holdings primarily present?

Zimmer Biomet Holdings Inc is primarily present in various countries and regions around the world. Some of the key markets where this company operates include the United States, Europe, Asia-Pacific, and Latin America. With a strong global presence, Zimmer Biomet Holdings Inc has established itself as a leading player in the medical device industry. Its presence in multiple countries and regions allows the company to serve a diverse range of customers and cater to the healthcare needs of patients worldwide.

What significant milestones has the company Zimmer Biomet Holdings achieved?

Zimmer Biomet Holdings Inc, a leading medical device company, has achieved significant milestones throughout its history. Firstly, the company's merger in 2015 between Zimmer Holdings and Biomet Inc increased its market presence and product portfolio. Zimmer Biomet has also introduced innovative products such as the Persona® Knee System, which offers personalized knee replacement options. Moreover, the company's ongoing commitment to research and development has led to advancements in surgical robotics and orthopedic implants. With its strong emphasis on patient outcomes, Zimmer Biomet has gained recognition for its quality systems and regulatory compliance. As a result, the company continues to establish itself as a trusted leader in the global healthcare industry.

What is the history and background of the company Zimmer Biomet Holdings?

Zimmer Biomet Holdings Inc, a leading global medical device company, has a rich history and background. It was formed in June 2015 through the merger of Zimmer Holdings and Biomet Inc. With a heritage dating back to 1927, Zimmer Biomet has been at the forefront of developing innovative solutions for orthopedic and musculoskeletal healthcare. The company focuses on providing products and services that enhance patients' quality of life, including joint reconstruction, spine and dental implants, sports medicine, and surgical technologies. Zimmer Biomet is committed to advancing medical science, improving patient care, and addressing the evolving needs of the healthcare industry.

Who are the main competitors of Zimmer Biomet Holdings in the market?

Some of the main competitors of Zimmer Biomet Holdings Inc in the market include Johnson & Johnson, Stryker Corporation, and Medtronic plc.

In which industries is Zimmer Biomet Holdings primarily active?

Zimmer Biomet Holdings Inc is primarily active in the medical device industry. With a strong focus on orthopedic and musculoskeletal healthcare, Zimmer Biomet specializes in designing, manufacturing, and marketing a wide range of innovative and technologically advanced surgical products and solutions. The company's offerings include joint replacement systems, surgical implants, robotics-assisted technology, trauma products, and dental prosthetics. Zimmer Biomet has expertise in serving patients, healthcare professionals, and hospitals worldwide, aiming to improve patients' quality of life through its diverse portfolio of products and commitment to advancing healthcare technologies.

What is the business model of Zimmer Biomet Holdings?

The business model of Zimmer Biomet Holdings Inc is focused on the research, development, and manufacturing of medical devices and orthopedic solutions. As a global leader in musculoskeletal healthcare, Zimmer Biomet provides innovative products and technologies for joint replacement, spine and trauma operations, dental implants, and sports medicine. The company collaborates with healthcare professionals to improve patient outcomes and enhance quality of life. Zimmer Biomet operates through three key segments: Orthopaedics, Dental, and Spine & CMF (Craniomaxillofacial). By consistently delivering advanced medical solutions, Zimmer Biomet aims to address the evolving healthcare needs of patients worldwide.

What is the P/E ratio of Zimmer Biomet Holdings 2024?

The Zimmer Biomet Holdings P/E ratio is 14.46.

What is the P/S ratio of Zimmer Biomet Holdings 2024?

The Zimmer Biomet Holdings P/S ratio is 2.99.

What is the Quality Investing of Zimmer Biomet Holdings?

The Quality Investing for Zimmer Biomet Holdings is 3/10.

What is the revenue of Zimmer Biomet Holdings 2024?

The expected Zimmer Biomet Holdings revenue is 7.74 B USD.

How high is the profit of Zimmer Biomet Holdings 2024?

The expected Zimmer Biomet Holdings profit is 1.6 B USD.

What is the business model of Zimmer Biomet Holdings

Zimmer Biomet Holdings Inc is a global leader in the medical device industry. The company offers a wide range of solutions for orthopedics, traumatology, spinal and dental surgery. Zimmer Biomet's orthopedic division produces a variety of products for use in knee, hip, shoulder, hand, elbow, and foot surgery. These products range from artificial joints and implants to surgical instruments and biological materials. Zimmer Biomet's traumatology division offers a wide range of products for the treatment of bone fractures, including fixation materials and devices for soft tissue reconstruction. Zimmer Biomet's spinal division focuses on the treatment of spine disorders, including herniated discs and spinal canal diseases. These products include spinal fusion systems and devices for minimally invasive spinal surgery. Zimmer Biomet's dental surgery division offers a wide range of implants, instruments, and materials for tooth and jaw reconstruction and rehabilitation. The business model of Zimmer Biomet aims to provide hospitals, clinics, and doctors with a comprehensive range of solutions for orthopedic, traumatology, spinal, and dental surgery applications. The company operates its business in over 100 countries worldwide and is committed to meeting the needs of its customers by investing continuously in research and development. Zimmer Biomet pursues a two-brand strategy with the Zimmer and Biomet brands. The company leverages its size and expertise to develop innovative products and services for its customers while also building a strong brand presence. The company has a strong global presence and is able to operate in all major markets. Zimmer Biomet focuses on offering innovative solutions to complex medical problems while providing a high level of customer service and training support. Overall, Zimmer Biomet relies on its reputation and industry knowledge to understand the needs of its customers and provide tailored solutions. The company continues to strive to expand its leadership position in the medical device industry and explore new opportunities for growth and expansion.

What is the Zimmer Biomet Holdings dividend?

Zimmer Biomet Holdings pays a dividend of 0.96 USD distributed over 4 payouts per year.

How often does Zimmer Biomet Holdings pay dividends?

Zimmer Biomet Holdings pays out a dividend 4 times a year.

What is the Zimmer Biomet Holdings ISIN?

The ISIN of Zimmer Biomet Holdings is US98956P1021.

What is the Zimmer Biomet Holdings WKN?

The WKN of Zimmer Biomet Holdings is 753718.

What is the Zimmer Biomet Holdings ticker?

The ticker of Zimmer Biomet Holdings is ZBH.

How much dividend does Zimmer Biomet Holdings pay?

Over the past 12 months, Zimmer Biomet Holdings paid a dividend of 0.96 USD . This corresponds to a dividend yield of about 0.87 %. For the coming 12 months, Zimmer Biomet Holdings is expected to pay a dividend of 0.97 USD.

What is the dividend yield of Zimmer Biomet Holdings?

The current dividend yield of Zimmer Biomet Holdings is 0.87 %.

When does Zimmer Biomet Holdings pay dividends?

Zimmer Biomet Holdings pays a quarterly dividend. This is distributed in the months of January, April, July, October.

How secure is the dividend of Zimmer Biomet Holdings?

Zimmer Biomet Holdings paid dividends every year for the past 18 years.

What is the dividend of Zimmer Biomet Holdings?

For the upcoming 12 months, dividends amounting to 0.97 USD are expected. This corresponds to a dividend yield of 0.89 %.

In which sector is Zimmer Biomet Holdings located?

Zimmer Biomet Holdings is assigned to the 'Health' sector.

Wann musste ich die Aktien von Zimmer Biomet Holdings kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Zimmer Biomet Holdings from 10/31/2024 amounting to 0.24 USD, you needed to have the stock in your portfolio before the ex-date on 9/30/2024.

When did Zimmer Biomet Holdings pay the last dividend?

The last dividend was paid out on 10/31/2024.

What was the dividend of Zimmer Biomet Holdings in the year 2023?

In the year 2023, Zimmer Biomet Holdings distributed 0.96 USD as dividends.

In which currency does Zimmer Biomet Holdings pay out the dividend?

The dividends of Zimmer Biomet Holdings are distributed in USD.

All fundamentals about Zimmer Biomet Holdings

Our stock analysis for Zimmer Biomet Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Zimmer Biomet Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.